Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 29:10:840617.
doi: 10.3389/fped.2022.840617. eCollection 2022.

The Effect of Vitamin D Supplementation in Children With Asthma: A Meta-Analysis

Meiqi Hao  1   2 , Ruoxin Xu  1   2 , Nachuan Luo  1   2 , Miaowen Liu  1   2 , Junping Xie  3 , Wenxiong Zhang  1
Affiliations

The Effect of Vitamin D Supplementation in Children With Asthma: A Meta-Analysis

Meiqi Hao et al. Front Pediatr. .

Abstract

Background: An increasing number of studies have suggested that vitamin D can be used to treat childhood asthma, but its clinical effects are still unclear. We conducted this meta-analysis to examine the latest estimates of the effectiveness and safety of using vitamin D to treat childhood asthma.

Methods: The PubMed, The Cochrane Library, ScienceDirect, Embase, Scopus, Ovid MEDLINE, Web of Science, and Google Scholar databases were searched for randomized controlled trials (RCTs) describing vitamin D supplementation interventions for asthmatic children. Asthma exacerbation, vitamin D levels, the predicted percentage of forced expiratory volume in the first second (FEV1%) and adverse effects (AEs) were analyzed as the main outcome measures.

Results: After screening, eight RCTs with 738 children were included. Compared with placebos, vitamin D supplementation had a stronger effect on serum vitamin D levels [mean difference (MD) = 13.51 (4.24, 22.79), p = 0.004]. The pooled results indicated that no significant changes were found between the groups in asthma control, as measured by adopting the following indicators: asthma exacerbation [risk ratio (RR) = 0.92 (0.68, 1.25), p = 0.60]; Childhood Asthma Control Test (CACT) scores [MD = 0.15 (-0.43, 0.74), p = 0.61]; hospitalizations for asthma exacerbation [RR = 1.20 (0.48, 2.96), p = 0.70]; acute care visits [RR = 1.13 (0.77, 1.65), p = 0.63]; steroid use [RR = 1.03 (0.41, 2.57), p = 0.95]; and fractional exhaled nitric oxide (FeNO) [MD =-3.95 (-22.87, 14.97), p = 0.68]. However, vitamin D supplementation might reduce the FEV1% [MD = -4.77 (-9.35, -0.19), p = 0.04] and the percentage of predicted forced vital capacity (FVC%) [MD =-5.01 (-9.99, -0.02), p = 0.05] in patients. Subgroup analysis revealed no difference in AEs between the two groups.

Conclusions: Vitamin D supplementation significantly increased patients' serum vitamin D levels, but it had no benefit for asthma control. However, vitamin D supplementation might reduce patients' lung function. It is essential to systemically search for more large-scale, rigorous, and well-designed RCTs to fully confirm these conclusions.

Systematic review registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021288838, PROSPERO CRD42021288838.

Keywords: asthma; children; meta-analysis; systematic review; vitamin D.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of study selection.
Figure 2
Figure 2
Forest plots of MD of vitamin D levels associated with vitamin D vs. placebo.
Figure 3
Figure 3
Forest plots of MD of CACT scores (A) and FeNO (B), and RR of asthma exacerbation (C), hospitalizations for asthma exacerbation (D), acute care visits (E), and steroid use (F) associated with vitamin D vs. placebo.
Figure 4
Figure 4
Forest plots MD of FEV1% (A), FVC% (B), and FEV1: FVC (C) associated with vitamin D vs. placebo.
See this image and copyright information in PMC

References

    1. Szefler SJ, Fitzgerald DA, Adachi Y, Doull IJ, Fischer GB, Fletcher M, et al. . A worldwide charter for all children with asthma. Pediatr Pulmonol. (2020) 55:1282–92. 10.1002/ppul.24713 - DOI - PMC - PubMed
    1. Asher MI, García-Marcos L, Pearce NE, Strachan DP. Trends in worldwide asthma prevalence. Eur Respir J. (2020) 56:2002094. 10.1183/13993003.02094-2020 - DOI - PubMed
    1. Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, et al. . Global Initiative for Asthma (GINA) strategy 2021-executive summary and rationale for key changes. Am J Respir Crit Care Med. (2022) 205:17–35. 10.1164/rccm.202109-2205pp - DOI - PMC - PubMed
    1. Boulet LP, Reddel HK, Bateman E, Pedersen S, FitzGerald JM, O'Byrne PM. The Global Initiative for Asthma (GINA): 25 years later. Eur Respir J. (2019) 54:1900598. 10.1183/13993003.00598-2019 - DOI - PubMed
    1. Mann EH, Chambers ES, Pfeffer PE, Hawrylowicz CM. Immunoregulatory mechanisms of vitamin D relevant to respiratory health and asthma. Ann N Y Acad Sci. (2014) 1317:57–69. 10.1111/nyas.12410 - DOI - PubMed

Publication types

LinkOut - more resources